Globe Newswire » trang 14 » Trang Công Nghệ | Trangcongnghe.vn

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

Globenewswire -

WillScot Reports Fourth Quarter and Full Year 2025 Results and Provides 2026 Outlook

WillScot Reports Fourth Quarter and Full Year 2025 Results and Provides 2026 Outlook

Globenewswire -

Sagtec Expands AI SaaS Monetization Strategy as Enterprise Pipeline Scales; Company Advances Toward AI-Native Recurring Revenue Model

Sagtec Expands AI SaaS Monetization Strategy as Enterprise Pipeline Scales; Company Advances Toward AI-Native Recurring Revenue Model

Globenewswire -

Salsify Powers AI-Driven Commerce at Enterprise Scale, Accelerating Customer Automation and Growth

Salsify Powers AI-Driven Commerce at Enterprise Scale, Accelerating Customer Automation and Growth

Globenewswire -

Coventry Announces Expanded Relationship with NAIFA

Coventry Announces Expanded Relationship with NAIFA

Globenewswire -

NBIM Signs Partnership with Credit Benchmark to Strengthen Insight into Unrated Counterparty Risk

NBIM Signs Partnership with Credit Benchmark to Strengthen Insight into Unrated Counterparty Risk

Globenewswire -

Philips publishes its Annual Report 2025

Philips publishes its Annual Report 2025

Globenewswire -

XEM THÊM TIN MỚI